Stacy Croteau, MD

Children's Hospital Boston · company speakers →

Dr. Stacy Croteau will present on the use of the novel therapeutic approach of substitution therapy for hemophilia prophylaxis, namely bispecific antibody technology. Therapeutic development and clinical implications of both licensed and investigational therapies in this category will be discussed.

Is this you? Claim this profile →